Research graph
References from Influence of CTG repeats from the human DM1 locus on murine gut microbiota. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1146/annurev.neuro.29.051605.113042
10.1146/annurev.neuro.29.051605.113042 · External reference
10.1126/science.1546326
10.1126/science.1546326 · External reference
10.1042/bst0371281
10.1042/bst0371281 · External reference
Unresolved reference
External reference
10.3748/wjg.v12.i12.1821
10.3748/wjg.v12.i12.1821 · External reference
The prevalence of faecal incontinence in myotonic dystrophy type 1
10.1016/j.nmd.2019.05.009 · 2019 · External reference
Gastrointestinal symptoms in myotonic dystrophy
10.3109/00365529609009145 · 1996 · External reference
Clinical and molecular insights into gastrointestinal dysfunction in myotonic dystrophy types 1 & 2
2022 · External reference
10.1212/cpj.0000000000000531
10.1212/cpj.0000000000000531 · External reference
Intestinal endocrine cells in myotonic dystrophy: an immunocytochemical and computed image analytical study
10.1046/j.1365-2796.1999.00413.x · 1999 · External reference
Gastric myoelectrical activity and gut hormone secretion in myotonic dystrophy
10.1097/00042737-200107000-00011 · 2001 · External reference
Assessment of autonomic nerve function in myotonic dystrophy
10.1016/0165-1838(90)90144-8 · 1990 · External reference
Smooth muscle involvement in primary muscle disease. I. Myotonic dystrophy
1967 · External reference
Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable
10.1002/mus.21787 · 2010 · External reference
Mechanisms of diarrhoea in myotonic dystrophy
10.1097/00042737-199807000-00015 · 1998 · External reference
10.1126/scitranslmed.aan5662
10.1126/scitranslmed.aan5662 · External reference
10.1016/j.ajpath.2023.10.010
10.1016/j.ajpath.2023.10.010 · External reference
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice
10.15252/emmm.202216244 · 2023 · External reference
DM1 Transgenic Mice Exhibit Abnormal Neurotransmitter Homeostasis and Synaptic Plasticity in Association with RNA Foci and Mis-Splicing in the Hippocampus
10.3390/ijms23020592 · 2022 · External reference
Mice lacking MBNL1 and MBNL2 exhibit sudden cardiac death and molecular signatures recapitulating myotonic dystrophy
2022 · External reference
Mbnl1 and Mbnl2 regulate brain structural integrity in mice
10.1038/s42003-021-02845-0 · 2021 · External reference
10.1016/j.omtm.2021.09.007
10.1016/j.omtm.2021.09.007 · External reference
10.1002/chem.201804368
10.1002/chem.201804368 · External reference
10.1074/jbc.m115.710616
10.1074/jbc.m115.710616 · External reference
10.1016/j.celrep.2015.11.028
10.1016/j.celrep.2015.11.028 · External reference
Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing
10.3390/ijms23094622 · 2022 · External reference
Pharmacological and exercise-induced activation of AMPK as emerging therapies for myotonic dystrophy type 1 patients
10.1113/jp282725 · 2022 · External reference
10.1038/s41551-021-00838-2
10.1038/s41551-021-00838-2 · External reference
10.1016/j.drudis.2018.08.004
10.1016/j.drudis.2018.08.004 · External reference
10.1016/j.csbj.2024.05.009 · Admitted local publication
10.1371/journal.pgen.1003043
10.1371/journal.pgen.1003043 · External reference
Gut microbiota determines the social behavior of mice and induces metabolic and inflammatory changes in their adipose tissue
10.1038/s41522-021-00193-9 · 2021 · External reference
10.1186/s40168-014-0050-9
10.1186/s40168-014-0050-9 · External reference
Potential interaction between timing of infant complementary feeding and breastfeeding duration in determination of early childhood gut microbiota composition and BMI
10.1111/ijpo.12642 · 2020 · External reference
10.1186/s12866-020-01724-8
10.1186/s12866-020-01724-8 · External reference
10.1038/ismej.2012.8
10.1038/ismej.2012.8 · External reference
10.1128/aem.01043-13
10.1128/aem.01043-13 · External reference
10.1038/nmeth.3869
10.1038/nmeth.3869 · External reference
10.1371/journal.pone.0061217
10.1371/journal.pone.0061217 · External reference
Unresolved reference
External reference
10.1093/nar/gks1219
10.1093/nar/gks1219 · External reference
Nonparametric Estimation of the Number of Classes in a Population
1984 · External reference
10.1002/j.1538-7305.1948.tb01338.x
10.1002/j.1538-7305.1948.tb01338.x · External reference
10.1038/163688a0
10.1038/163688a0 · External reference
A new method for non-parametric multivariate analysis of variance
2001 · External reference
Analysis of composition of microbiomes: a novel method for studying microbial composition
2015 · External reference
Clinical Significance of Hepatocyte Growth Factor and Transforming Growth Factor-Beta-1 Levels in Assessing Disease Activity in Inflammatory Bowel Disease
2020 · External reference
10.1023/b:joci.0000018066.46279.6b
10.1023/b:joci.0000018066.46279.6b · External reference
Exploring the role of IL-1β in inflammatory bowel disease pathogenesis
2024 · External reference
C-X-C Motif Chemokine Ligand 1 Promotes Colitis by Modulating the Gut Microbiota
10.1159/000535637 · 2023 · External reference
Functional and histopathological identification of the respiratory failure in a DMSXL transgenic mouse model of myotonic dystrophy
2013 · External reference
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study
2020 · External reference
Gastric Adenocarcinomas and Signet-Ring Cell Carcinoma: Unraveling Gastric Cancer Complexity through Microbiome Analysis—Deepening Heterogeneity for a Personalized Therapy
10.3390/ijms21249735 · 2020 · External reference
Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer
10.1038/srep04202 · 2014 · External reference
10.1097/meg.0000000000000542
10.1097/meg.0000000000000542 · External reference
Gut Dysbiosis and the Intestinal Microbiome: Streptococcus thermophilus a Key Probiotic for Reducing Uremia
10.3390/microorganisms7080228 · 2019 · External reference
Lactobacillus acidophilus LB: a useful pharmabiotic for the treatment of digestive disorders
10.1177/1756284820971201 · 2020 · External reference
Streptococcus thermophilus Attenuates Inflammation in Septic Mice Mediated by Gut Microbiota
2020 · External reference
Lycium barbarum polysaccharide attenuates myocardial injury in high-fat diet-fed mice through manipulating the gut microbiome and fecal metabolome
10.1016/j.foodres.2020.109778 · 2020 · External reference
10.1016/j.foodres.2021.110530
10.1016/j.foodres.2021.110530 · External reference
The Therapeutic Efficacy of Curcumin vs. Metformin in Modulating the Gut Microbiota in NAFLD Rats: A Comparative Study
2021 · External reference
Romboutsia lituseburensis JCM1404 supplementation ameliorated endothelial function via gut microbiota modulation and lipid metabolisms alterations in obese rats
10.1093/femsle/fnad016 · 2023 · External reference
Gut Microbiome of Indonesian Adults Associated with Obesity and Type 2 Diabetes: A Cross-Sectional Study in an Asian City, Yogyakarta
10.3390/microorganisms9050897 · 2021 · External reference
Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities
10.1038/s41598-019-49462-w · 2019 · External reference
A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota
2018 · External reference
Unresolved reference
2017 · External reference
10.1111/odi.13843
10.1111/odi.13843 · External reference
The Anti-Inflammatory Effect and Mucosal Barrier Protection of Clostridium butyricum RH2 in Ceftriaxone-Induced Intestinal Dysbacteriosis
2021 · External reference
10.1038/mi.2008.84
10.1038/mi.2008.84 · External reference
C-C Motif Ligand 20 (CCL20) and C-C Motif Chemokine Receptor 6 (CCR6) in Human Peripheral Blood Mononuclear Cells: Dysregulated in Ulcerative Colitis and a Potential Role for CCL20 in IL-1β Release
10.3390/ijms19103257 · 2018 · External reference
CCR6–CCL20 Axis in IBD: What Have We Learnt in the Last 20 Years?
10.3390/gidisord1010006 · 2019 · External reference
Expression of chemokine CCL20 in ulcerative colitis
10.3892/mmr.2012.1088 · 2012 · External reference
10.1189/jlb.0103024
10.1189/jlb.0103024 · External reference
10.4049/jimmunol.1601410
10.4049/jimmunol.1601410 · External reference
Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence
10.1002/ibd.22839 · 2012 · External reference
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy
10.15252/emmm.202216225 · 2023 · External reference
10.1038/s41593-022-01027-3
10.1038/s41593-022-01027-3 · External reference
